RESUMO
OBJECTIVE: To explore the clinical and genetic characteristics of a neonate with Microvillus inclusion disease (MVID). METHODS: A neonate with MVID admitted to the First Affiliated Hospital of Zhengzhou University in May 2019 was selected as the study subject. Clinical data were collected. Whole exome sequencing (WES) was carried out, and candidate variants were verified by Sanger sequencing and multiple ligation-dependent probe amplification (MLPA). A literature was also carried out to summarize the clinical and genetic characteristics of MVID. RESULTS: The prematurely born neonate had presented with unexplained refractory diarrhea and metabolic acidosis. Active symptomatic treatment was ineffective, and the child had died at 2 months old. WES revealed that he had harbored compound heterozygous variants of the MYO5B gene, namely c.1591C>T (p.R531W) and deletion of exon 9. Sanger sequencing showed that the R531W variant was inherited form his father, and MLPA confirmed that the exon 9 deletion was inherited from his mother. Seven children with MVID were reported in China, of which one was lost during follow-up and six had deceased. One hundred eighty eight patients were reported worldwide and only one was cured. The clinical features of MVID had included refractory diarrhea, metabolic acidosis and poor prognosis. CONCLUSION: The child was diagnosed with MVID due to the compound heterozygous variants of the MYO5B gene, which has provided a basis for genetic counseling and prenatal diagnosis.
Assuntos
Acidose , Síndromes de Malabsorção , Microvilosidades , Mucolipidoses , Miosina Tipo V , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Gravidez , Diarreia/genética , Síndromes de Malabsorção/genética , Microvilosidades/patologia , Mucolipidoses/genética , Cadeias Pesadas de Miosina , Miosina Tipo V/genéticaAssuntos
Atrofia , Microvilosidades , ATPases Vacuolares Próton-Translocadoras , Animais , Microvilosidades/patologia , Microvilosidades/metabolismo , Atrofia/patologia , ATPases Vacuolares Próton-Translocadoras/metabolismo , ATPases Vacuolares Próton-Translocadoras/genética , Regulação para Baixo , Humanos , Camundongos , Intestinos/patologia , Mucosa Intestinal/patologia , Mucosa Intestinal/metabolismoRESUMO
Microvillus inclusion disease (MVID) is a rare condition that is present from birth and affects the digestive system. People with MVID experience severe diarrhea that is difficult to control, cannot absorb dietary nutrients, and struggle to grow and thrive. In addition, diverse clinical manifestations, some of which are life-threatening, have been reported in cases of MVID. MVID can be caused by variants in the MYO5B, STX3, STXBP2, or UNC45A gene. These genes produce proteins that have been functionally linked to each other in intestinal epithelial cells. MVID associated with STXBP2 variants presents in a subset of patients diagnosed with familial hemophagocytic lymphohistiocytosis type 5. MVID associated with UNC45A variants presents in most patients diagnosed with osteo-oto-hepato-enteric syndrome. Furthermore, variants in MYO5B or STX3 can also cause other diseases that are characterized by phenotypes that can co-occur in subsets of patients diagnosed with MVID. Recent studies involving clinical data and experiments with cells and animals revealed connections between specific phenotypes occurring outside of the digestive system and the type of gene variants that cause MVID. Here, we have reviewed these patterns and correlations, which are expected to be valuable for healthcare professionals in managing the disease and providing personalized care for patients and their families.
Assuntos
Síndromes de Malabsorção , Microvilosidades , Mucolipidoses , Fenótipo , Humanos , Mucolipidoses/genética , Mucolipidoses/patologia , Microvilosidades/patologia , Microvilosidades/genética , Síndromes de Malabsorção/genética , Síndromes de Malabsorção/patologia , Animais , Miosina Tipo V/genética , Miosina Tipo V/metabolismo , Mutação , Predisposição Genética para DoençaRESUMO
Congenital diarrhea and enteropathies (CODEs) constitute a group of rare genetic disorders characterized by severe diarrhea and malabsorption in the neonatal period or early infancy. Timely diagnosis and treatment is essential to prevent life-threatening complications, including dehydration, electrolyte imbalance, and malnutrition. This review offers a simplified approach to the diagnosis of CODEs, with a specific focus on microvillus inclusion disease (MVID), congenital tufting enteropathy (CTE), congenital chloride diarrhea (CLD), and congenital sodium diarrhea (CSD). Patients with CODEs typically present with severe watery or occasionally bloody diarrhea, steatorrhea, dehydration, poor growth, and developmental delay. Therefore, it is crucial to thoroughly evaluate infants with diarrhea to rule out infectious, allergic, or anatomical causes before considering CODEs as the underlying etiology. Diagnostic investigations for CODEs encompass various modalities, including stool tests, blood tests, immunological studies, endoscopy and biopsies for histology and electron microscopy, and next-generation sequencing (NGS). NGS plays a pivotal role in identifying the genetic mutations responsible for CODEs. Treatment options for CODEs are limited, often relying on total parenteral nutrition for hydration and nutritional support. In severe cases, intestinal transplantation may be considered. The long-term prognosis varies among specific CODEs, with some patients experiencing ongoing intestinal failure and associated complications. In conclusion, the early recognition and accurate diagnosis of CODEs are of paramount importance for implementing appropriate management strategies. Further research and advancements in genetic testing hold promise for enhancing diagnostic accuracy and exploring potential targeted therapies for these rare genetic disorders.
Assuntos
Diarreia , Síndromes de Malabsorção , Humanos , Diarreia/terapia , Diarreia/etiologia , Diarreia/congênito , Síndromes de Malabsorção/terapia , Síndromes de Malabsorção/diagnóstico , Síndromes de Malabsorção/genética , Recém-Nascido , Lactente , Erros Inatos do Metabolismo/diagnóstico , Erros Inatos do Metabolismo/terapia , Erros Inatos do Metabolismo/genética , Mucolipidoses/diagnóstico , Mucolipidoses/terapia , Mucolipidoses/genética , Microvilosidades/patologia , Enteropatias/diagnóstico , Enteropatias/terapia , Enteropatias/genética , Anormalidades Múltiplas , Diarreia InfantilRESUMO
Las diarreas congénitas son patologías graves de baja frecuencia y alta mortalidad. Se manifiestan durante los primeros días o meses de vida con severa diarrea, generando insuficiencia intestinal y dependencia de nutrición parenteral. Se debe sospechar ante un recién nacido o lactante con pérdidas masivas hidroelectrolíticas, y se diagnostican utilizando parámetros clínicos, endoscópicos, histológicos y eventualmente genéticos. El tratamiento es de soporte, con reposición hidroelectrolítica intensa y nutricional. OBJETIVO: Presentar un caso de diarrea congénita, identificada como Enfermedad por Inclusión Microvellositaria, de presentación neonatal. CASO CLÍNICO: Paciente varón edad actual 3 años, hijo de padres consanguíneos, quien debutó a los 10 días de vida con diarrea secretora severa, requiriendo ingreso a unidad de paciente crítico y nutrición parenteral permanente. Inicialmente además con síndrome de Fanconi, que luego se recupera. Se confirmó la sospecha de Enfermedad de Inclusión Microvellositaria utilizando microscopia óptica, electrónica e inmunohistoquímica. Se obtuvo una favorable evolución utilizando nutrición parenteral total (NPT) a domicilio. CONCLUSIONES: Se presenta el primer caso conocido en Chile de un paciente con diarrea congénita por inclusión microvellositaria manejado y su evolución.
Congenital diarrheas correspond to a severe and low frequency digestive disease, with a high mortality. They start a few days or months after birth, leading to intestinal insufficiency and dependence on parenteral nutrition. It must be highly suspected in newborns or infants with diarrhea and severe electrolyte disorders. The diagnosis is based on clinical, endoscopic, histologic and eventually genetic findings. Treatment is supportive with intensive correction of electrolyte imbalances as well as parenteral nutrition. OBJECTIVE: To present a case report of congenital diarrhea identified as microvillous inclusion disease presenting in the neonatal period. CASE REPORT: Male patient currently 3 years of age, son of consanguineous parents. At 10 days of age presents a severe secretory diarrhea, requiring treatment in a critical care unit and parenteral nutrition. Initially he also presented with Fanconi syndrome, which improved afterwards. The suspicion of congenital microvillous inclusion was confirmed later by optic and electronic microscopy, and inmunohistochemistry. A succesful evolution was later achieved maintaining home parenteral nutrition after discharge. CONCLUSION: We present the first known case in Chile of congenital diarrhea due to microvillous inclusión disease and his evolution.
Assuntos
Humanos , Masculino , Recém-Nascido , Pré-Escolar , Diarreia/congênito , Síndromes de Malabsorção/diagnóstico , Microvilosidades/patologia , Mucolipidoses/diagnóstico , Índice de Gravidade de Doença , Chile , Progressão da Doença , Diarreia/etiologia , Síndromes de Malabsorção/complicações , Mucolipidoses/complicaçõesRESUMO
Mycophenolate mofetil (MMF) is an immunosupressor agent frequently used in patients after bone marrow or solid organ transplants. The most common adverse reactions of the drug are gastrointestinal, specially diarrhea and vomiting. We report a 53-year-old male, that received a heart transplant receiving immunosuppression with cyclosporine, mycophenolate mofetil and prednisone. Six months after the transplant, the patient started with diarrhea, anorexia and weight loss. A duodenal biopsy showed villous atrophy. Celiac disease and the presence of parasites were discarded. Mycophenolate mofetil was discontinued and one week later, diarrhea subsided. Two months later the patient was asymptomatic and recovered weight. A new duodenal biopsy showed absence of villous atrophy.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Duodeno/patologia , Imunossupressores/efeitos adversos , Microvilosidades/patologia , Ácido Micofenólico/análogos & derivados , Atrofia , Biópsia , Transplante de Coração/imunologia , Transplante de Rim/imunologia , Ácido Micofenólico/efeitos adversosRESUMO
T lymphocyte-mediated pathogenesis is common to a variety of enteropathies, including giardiasis, cryptosporidiosis, bacterial enteritis, celiac's disease, food anaphylaxis, and Crohn's disease. In giardiasis as well as in these other disorders, a diffuse loss of microvillous brush border, combined or not with villus atrophy, is responsible for disaccharidase insufficiencies and malabsorption of electrolytes, nutrients, and water, which ultimately cause diarrheal symptoms. Other mucosal changes may include crypt hyperplasia and increased infiltration of intra-epithelial lymphocytes. Recent studies using models of giardiasis have shed new light on the immune regulation of these abnormalities. Indeed, experiments using an athymic mouse model of infection have found that these epithelial injuries were T cell-dependent. Findings from further research indicate that that the loss of brush border surface area, reduced disaccharidase activities, and increase crypt-villus ratios are mediated by CD8+ T cells, whereas both CD8+ and CD4+ small mesenteric lymph node T cells regulate the influx of intra-epithelial lymphocytes. Future investigations need to characterize the CD8+ T cell signaling cascades that ultimately lead to epithelial injury and malfunction in giardiasis and other malabsorptive disorders of the intestine.
Assuntos
Animais , Humanos , /imunologia , /imunologia , Giardíase/patologia , Mucosa Intestinal/patologia , Giardíase/imunologia , Mucosa Intestinal/imunologia , Mucosa Intestinal/parasitologia , Microvilosidades/parasitologia , Microvilosidades/patologiaRESUMO
Se estudió el intestino medio abdominal de Lutzomyia ovallesi infectada con Leishmania (Leishmania) amazonensis. Las hembras se observaron a los siete días post- infección, utilizando microscopía de luz de alta resolución y microscopía electrónica de transmisión. Se distinguieron dos tipos de células epiteliales, células digestivas y células secretoras, en el intestino medio abdominal de L. ovallesi, tanto en los insectos controles como en flebotominos infectados. Los resultados muestran además, que L. ovallesi presentó alteraciones en la citoar-quitectura celular del intestino medio abdominal producto de la infección con L. (L.) amazonensis, observándose gran distensión del diámetro de la luz intestinal, degeneración de sus células, pérdida parcial o total de las microvellosidades y engrosamiento de la capa basal de toda la porción del intestino. Las células epiteliales presentaron degeneración vacuolar y mitocondrial y en la luz intestinal se observaron desechos epiteliales. El daño celular observado en el intestino medio abdominal de L. ovallesi, pueden tener relación con la secreción de lectinas y con la formación del gel observado, semejante a una matriz, en el lumen del intestino. Es necesario continuar los estudios para dilucidar aspectos importantes de la interrelación Leishmania-vector.
Assuntos
Animais , Células Epiteliais/ultraestrutura , Intestinos/patologia , Leishmania mexicana/patogenicidade , Psychodidae/parasitologia , Psychodidae/ultraestrutura , Microscopia Eletrônica , Microvilosidades/patologia , Mucosa Intestinal/patologia , Interações Hospedeiro-ParasitaRESUMO
CG 10-248 (3,4-dihydro-2,2-dimethyl-9-chloro-2H-naphtho[1,2b]pyran-5,6-dione; CG-NQ), a beta-lapachone analogue, modified the ultrastructure of rat hepatocytes, as demonstrated by light and electron microscopy. After 4 h incubation with 100 microM CG-NQ, the following effects were observed: (a) nuclear chromatin condensation; (b) chromatin fragmentation; (c) displacement of mitochondria, concentrated around the nucleus; (d) disruption or expansion of mitochondrial outer or inner membranes, respectively; (e) displacement and alteration of endoplasmic reticulum (rough and smooth); (f) decrease of microvilli; (g) blebbing of plasma membrane and production of apoptotic bodies formed by folding of plasma membrane fragments around mitochondria or peroxysomes; and (h) production of hydrogen peroxide. Expression of such effects varied according to hepatocyte samples and taken together strongly support an apoptotic action of CG-NQ dependent on reactive oxygen species.
Assuntos
Humanos , Masculino , Apoptose/efeitos dos fármacos , Hepatócitos/efeitos dos fármacos , Naftoquinonas/farmacologia , Naftoquinonas/toxicidade , Apoptose/fisiologia , Células Cultivadas , Cromatina/efeitos dos fármacos , Cromatina/patologia , Extensões da Superfície Celular/efeitos dos fármacos , Extensões da Superfície Celular/patologia , Extensões da Superfície Celular/ultraestrutura , Fragmentação do DNA/efeitos dos fármacos , Fragmentação do DNA/fisiologia , Hepatócitos/metabolismo , Hepatócitos/ultraestrutura , Microscopia Eletrônica , Membranas Intracelulares/efeitos dos fármacos , Membranas Intracelulares/patologia , Membranas Intracelulares/ultraestrutura , Microvilosidades/efeitos dos fármacos , Microvilosidades/patologia , Microvilosidades/ultraestrutura , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Mitocôndrias/ultraestrutura , Peróxido de Hidrogênio/metabolismo , Ratos , Ratos Wistar , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/patologia , Retículo Endoplasmático/ultraestruturaRESUMO
CG 10-248 (3,4-dihydro-2,2-dimethyl-9-chloro-2H-naphtho[1,2b]pyran-5,6-dione; CG-NQ), a beta-lapachone analogue, modified the ultrastructure of rat hepatocytes, as demonstrated by light and electron microscopy. After 4 h incubation with 100 microM CG-NQ, the following effects were observed: (a) nuclear chromatin condensation; (b) chromatin fragmentation; (c) displacement of mitochondria, concentrated around the nucleus; (d) disruption or expansion of mitochondrial outer or inner membranes, respectively; (e) displacement and alteration of endoplasmic reticulum (rough and smooth); (f) decrease of microvilli; (g) blebbing of plasma membrane and production of apoptotic bodies formed by folding of plasma membrane fragments around mitochondria or peroxysomes; and (h) production of hydrogen peroxide. Expression of such effects varied according to hepatocyte samples and taken together strongly support an apoptotic action of CG-NQ dependent on reactive oxygen species. (AU)
Assuntos
Humanos , Masculino , RESEARCH SUPPORT, NON-U.S. GOVT , Apoptose/efeitos dos fármacos , Hepatócitos/efeitos dos fármacos , Naftoquinonas/farmacologia , Naftoquinonas/toxicidade , Apoptose/fisiologia , Extensões da Superfície Celular/efeitos dos fármacos , Extensões da Superfície Celular/patologia , Extensões da Superfície Celular/ultraestrutura , Células Cultivadas , Cromatina/efeitos dos fármacos , Cromatina/patologia , Fragmentação do DNA/efeitos dos fármacos , Fragmentação do DNA/fisiologia , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/patologia , Retículo Endoplasmático/ultraestrutura , Hepatócitos/metabolismo , Hepatócitos/ultraestrutura , Peróxido de Hidrogênio/metabolismo , Membranas Intracelulares/efeitos dos fármacos , Membranas Intracelulares/patologia , Membranas Intracelulares/ultraestrutura , Microscopia Eletrônica , Microvilosidades/efeitos dos fármacos , Microvilosidades/patologia , Microvilosidades/ultraestrutura , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Mitocôndrias/ultraestrutura , Ratos , Ratos WistarRESUMO
The syndrome of protracted diarrhea (PD) includes several diseases with diverse etiologies. This study was conducted to characterize the spectrum of causes, clinical manifestations, and the outcomes of PD. A retrospective analysis of the clinical and pathological findings was performed on 25 patients with diarrhea starting within the first 2 yr of life and a requirement of parenteral nutrition (PN). According to the intestinal histopathology, patients were classified into four groups: immune enteropathy (12 cases), lymphangiectasia (6 cases), epithelial dysplasia (5 cases), and unclassified (2 cases). All patients with epithelial dysplasia had earlier onset of diarrhea and longer duration of PN than those in the other groups. Three patients (12%) had an evidence of a familial condition. Five patients (three with microvillous inclusion disease and two with immune enteropathy) died. Sixteen patients recovered, and three (two with primary lymphangiectasia and one with microvillous inclusion disease) still had diarrhea. One patient underwent intestinal transplantation for tufting enteropathy. In conclusion, infants with PD should be referred to specialized centers where advanced diagnostic and therapeutic facilities are available, because histological analysis is critical for the diagnosis of PD, and PN or intestinal transplantation is the only therapeutic option in a subset of cases.